Co-targeting CDK46 and AKT with endocrine therapy prevents progression in CDK46 inhibitor and endocrine therapy-resistant breast cancer.pdf-_-_-081661b9-9d7e-4bdd-9497-8e5505da7c60.pdf
CDK46 和 AKT 与内分泌疗法联合靶向可阻止 CDK46 抑制剂和内分泌疗法耐药性乳腺癌的进展.docx-_-_-959967c7-413f-4adf-837d-305ab6f71a8a.docx